XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares and Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated  Other Comprehensive Loss, Net of Tax
Non- controlling Interests
Beginning Balance (in shares) at Dec. 31, 2020   225.5      
Beginning Balance at Dec. 31, 2020 $ 3,583 $ 6,314 $ 1,042 $ (3,861) $ 88
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 933   913   20
Shares issued - employee stock compensation plans (in shares)   0.9      
Shares issued - employee stock compensation plans (87) $ (87)      
Shares purchased (in shares)   (0.2)      
Shares purchased (50)   (50)    
Share-based compensation expense 131 $ 131      
Dividends to shareholders (104)   (104)    
Net change in fair value of financial instruments 11     11  
Net foreign currency translation adjustments (70)     (70)  
Net postretirement benefit obligation 29     29  
Purchases of subsidiary shares from noncontrolling interests (14) $ (8)     (6)
Dividends paid to noncontrolling interests on subsidiary common stock (1)       (1)
Ending Balance (in shares) at Mar. 31, 2021   226.2      
Ending Balance at Mar. 31, 2021 $ 4,361 $ 6,350 1,801 (3,891) 101
Beginning Balance (in shares) at Dec. 31, 2021 214.8 214.8      
Beginning Balance at Dec. 31, 2021 $ 1,158 $ 6,626 (1,694) (3,871) 97
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,048   1,023   25
Shares issued - employee stock compensation plans (in shares)   0.9      
Shares issued - employee stock compensation plans (116) $ (116)      
Shares purchased (in shares)   (2.8)      
Shares purchased (828)   (828)    
Share-based compensation expense 119 $ 119      
Dividends to shareholders (110)   (110)    
Net change in fair value of financial instruments 1     1  
Net foreign currency translation adjustments (7)     (6) (1)
Net postretirement benefit obligation 33     33  
Dividends paid to noncontrolling interests on subsidiary common stock $ (7)       (7)
Ending Balance (in shares) at Mar. 31, 2022 212.9 212.9      
Ending Balance at Mar. 31, 2022 $ 1,291 $ 6,629 $ (1,609) $ (3,843) $ 114